Integrase inhibitors
Integrase Inhibitors
Integrase inhibitors (pronounced in-teg-ruh-se in-hib-it-ors) are a type of antiretroviral medication used in the treatment of HIV and other retroviruses.
Etymology
The term "integrase inhibitors" is derived from the function of the medication. "Integrase" refers to the viral enzyme that the medication inhibits, and "inhibitors" refers to the action of the medication.
Function
Integrase inhibitors work by blocking the action of integrase, a viral enzyme that HIV uses to infect T cells. By inhibiting this enzyme, the medication prevents the virus from integrating its genetic material into the host cell, thereby preventing the virus from replicating and spreading.
Examples
Examples of integrase inhibitors include Raltegravir, Elvitegravir, and Dolutegravir. These medications are often used in combination with other antiretroviral medications to provide a complete treatment regimen for HIV.
Related Terms
- Antiretroviral therapy: The use of medications to manage HIV and prevent its progression to AIDS.
- Viral enzyme: A protein produced by a virus that facilitates its replication.
- T cells: A type of white blood cell that plays a key role in the immune response.
- Raltegravir: An integrase inhibitor used in the treatment of HIV.
- Elvitegravir: An integrase inhibitor used in the treatment of HIV.
- Dolutegravir: An integrase inhibitor used in the treatment of HIV.
External links
- Medical encyclopedia article on Integrase inhibitors
- Wikipedia's article - Integrase inhibitors
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski